Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?

Mathijs P. Scholtes; Geert J.L.H. van Leenders; Debbie G.J. Robbrecht; Joost L. Boormans; Tahlita C.M. Zuiverloon

doi:10.21037/tau-24-112

Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?

Mathijs P. Scholtes, Geert J.L.H. van Leenders, Debbie G.J. Robbrecht, Joost L. Boormans, Tahlita C.M. Zuiverloon^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	1341-1345
Number of pages	5
Journal	Translational Andrology and Urology
Volume	13
Issue number	8
DOIs	https://doi.org/10.21037/tau-24-112
Publication status	Published - 31 Aug 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/tau-24-112Licence: CC BY-NC-ND

tau-13-08-1341Final published version, 147 KBLicence: CC BY-NC-ND

Cite this

@article{c3733552a9b74abd819e840b20d283da,

title = "Are primary tumors suitable for biomarker-guided treatment of metastatic urothelial cancer?",

author = "Scholtes, {Mathijs P.} and {van Leenders}, {Geert J.L.H.} and Robbrecht, {Debbie G.J.} and Boormans, {Joost L.} and Zuiverloon, {Tahlita C.M.}",

year = "2024",

month = aug,

day = "31",

doi = "10.21037/tau-24-112",

language = "English",

volume = "13",

pages = "1341--1345",

journal = "Translational Andrology and Urology",

issn = "2223-4683",